BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Monday, April 29, 2024
Home
»
Newsletters
» BioWorld
BioWorld
June 17, 2002
View Archived Issues
FDA Asks Biogen To Clarify Info On Amevive, But No Trial Needed
The FDA's positive feedback on Biogen Inc.'s Amevive application likely will be the first in a series of key events expected to drive the biotechnology industry this year, an analyst said.(BioWorld Today)
Read More
SciClone Gets $10.6M 'Insurance' Financing To Advance Zadaxin
Read More
Air Strikes, Not Ground Attacks, To Destroy Immune Cytokines Of Lethal Graft-Versus-Host Disease
Read More
Abbott Reports Positive Data From Anti-TNF RA Antibody
Read More
Other News To Note
Read More
Appointments And Advancements
Read More